|
71 |
Arterial Stiffness
Enthalten in High blood pressure & cardiovascular prevention Bd. 18, 27.11.2012, Nr. 1, date:3.2011: 1-12
|
|
|
|
72 |
Asenapine
Enthalten in CNS drugs Bd. 25, 1.3.2011, Nr. 3, date:3.2011: 251-267
|
|
|
|
73 |
Asenapine Pharmacokinetics in Hepatic and Renal Impairment
Enthalten in Clinical pharmacokinetics Bd. 50, 13.9.2012, Nr. 7, date:7.2011: 471-481
|
|
|
|
74 |
Aspirin for Primary Prevention of Cardiovascular Events in the Elderly
Enthalten in Drugs & aging Bd. 29, 31.8.2012, Nr. 4, date:4.2012: 251-258
|
|
|
|
75 |
Assessing the Quality of Pharmacoeconomic Studies in India
Enthalten in PharmacoEconomics Bd. 30, 27.12.2012, Nr. 9, date:9.2012: 749-762
|
|
|
|
76 |
Augmented Renal Clearance
Enthalten in Clinical pharmacokinetics Bd. 49, 13.9.2012, Nr. 1, date:1.2010: 1-16
|
|
|
|
77 |
Azacitidine
Enthalten in Drugs Bd. 72, 10.12.2012, Nr. 8, date:5.2012: 1111-1136
|
|
|
|
78 |
Bacteraemic Pneumococcal Pneumonia
Enthalten in Drugs Bd. 71, 18.11.2012, Nr. 2, date:1.2011: 131-153
|
|
|
|
79 |
Base the antibacterial treatment of community-acquired pneumonia on disease severity and other factors
Enthalten in Drugs & therapy perspectives Bd. 28, 30.8.2012, Nr. 5, date:5.2012: 15-19
|
|
|
|
80 |
Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
Enthalten in PharmacoEconomics Bd. 27, 17.9.2012, Nr. 12, date:12.2009: 1017-1029
|
|
Administration
